help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 36, No. 2 381-384
doi:10.1210/jcem-36-2-381
Copyright © 1973 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FELDMAN, K. B.
Right arrow Articles by CARTER, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FELDMAN, K. B.
Right arrow Articles by CARTER, A. C.

Diethylstilbestrol and Circulating Lipids in Women with Metastatic Breast Cancer: Lack of Dose Response over Three Log Units

KLAINK B. FELDMAN and ANNE C. CARTER

Department of Medicine, State University of New York Downstate Medical Center, and The Medical Services, The Kings County Hospital and The State University Hospital Brooklyn, New York

Thirty-five women with progressive metastatic breast cancer were treated in a double blind study with diethylstilbestrol in doses of 1.5, 15, 150, or 1500 mg daily. Plasma lipids and lipoproteins were measured serially in samples obtained from fasting patients. The pretreatment value for each variable was paired with the arithmetic mean of all values obtained during treatment. Plasma triglycerides increased 88% and plasma phospholipids rose 15% with therapy. There was no significant difference in mean responses of patients among the 4-dose levels, with increases apparent by 2 weeks of treatment, and stable as long as 2 yr. Plasma total cholesterol was unchanged with the estrogen therapy, although high-density liproprotein cholesterol increased. Serum immunoreactive insulin and plasma free fatty acids and glycerol did not change significantly. These data indicate that estrogen effects on circulating lipids accompanying pharmacologic doses of the hormone are independent of dosage.

This study was supported, in part, by USPHS Research Grants CA-33S8 and CA-3601 and by a grant-in-aid from The Ayerst Laboratories. Requests for reprints should be directed to Anne C. Carter, Box 21, State University of New York Downstate Medical Center, Brooklyn, New York 11203.

Received January 24, 1972.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1973 by The Endocrine Society